How the direct oral anticoagulant apixaban affects thrombin generation parameters

Thrombosis Research

Volumn 135, Issue 6, 2015, Pages 1186-1190

  Tripodi, Armando ^a,b   Padovan, Lidia ^a,b   Veena, Chantarangkul ^a,b   Scalambrino, Erica ^a,b   Testa, Sophie ^c   Peyvandi, Flora ^a,b  

^a UNIVERSITY OF MILAN   (Italy)

^b FONDAZIONE IRCCS CA GRANDA OSPEDALE MAGGIORE POLICLINICO   (Italy)

^c GENERAL HOSPITAL   (Italy)

Author keywords

Anticoagulants; Partial thromboplastin time; Prothrombin time; Thrombomodulin; Thrombosis

Indexed keywords

APIXABAN; PROTHROMBIN; THROMBIN; THROMBOMODULIN; ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 10A INHIBITOR; PYRAZOLE DERIVATIVE; PYRIDONE DERIVATIVE;

ANTICOAGULATION; ARTICLE; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG EFFECT; HUMAN; LAG TIME; NORMAL HUMAN; PARTIAL THROMBOPLASTIN TIME; PRIORITY JOURNAL; BIOSYNTHESIS; BLOOD CLOTTING; BLOOD CLOTTING TEST; CHEMISTRY; DOSE RESPONSE; DRUG EFFECTS; ORAL DRUG ADMINISTRATION; PROTHROMBIN TIME; TIME FACTOR;

ADMINISTRATION, ORAL; ANTICOAGULANTS; BLOOD COAGULATION; BLOOD COAGULATION TESTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FACTOR XA INHIBITORS; HUMANS; PARTIAL THROMBOPLASTIN TIME; PROTHROMBIN TIME; PYRAZOLES; PYRIDONES; THROMBIN; THROMBOMODULIN; TIME FACTORS;

EID: 84929519341     PISSN: 00493848     EISSN: 18792472     Source Type: Journal    
DOI: 10.1016/j.thromres.2015.03.032     Document Type: Article

References (22)

1. J. Dinkelaar, S. Patiwael, J. Harenberg, A. Leyte, and H.J. Brinkman Global coagulation tests: their applicability for measuring direct factor Xa- and thrombin inhibition and reversal of anticoagulation by prothrombin complex concentrate Clin Chem Lab Med 2014 10.1515/cclm-2014-0307
2. R. Herrmann, J. Thom, A. Wood, M. Phillips, S. Muhammad, and R. Baker Thrombin generation using the calibrated automated thrombinoscope to assess reversibility of dabigatran and rivaroxaban Thromb Haemost 111 2014 989 995
3. P.C. Wong, A. White, and J. Luettgen Inhibitory effect of apixaban compared with rivaroxaban and dabigatran on thrombin generation assay Hosp Pract (1995) 41 2013 19 25
4. B. Dale, J.W. Eikelboom, J.I. Weitz, E. Young, J.S. Paikin, and M. Coppens Dabigatran attenuates thrombin generation to a lesser extent than warfarin: could this explain their differential effects on intracranial hemorrhage and myocardial infarction? J Thromb Thrombolysis 35 2013 295 301
5. V. Serebruany, Y. Sani, D. Lynch, A. Schevchuck, S. Svetlov, and A. Fong Effects of dabigatran in vitro on thrombin biomarkers by Calibrated Automated Thrombography in patients after ischemic stroke J Thromb Thrombolysis 33 2012 22 27
6. G. Escolar, V. Fernandez-Gallego, E. Arellano-Rodrigo, J. Roquer, J.C. Reverter, and V.V. Sanz Reversal of apixaban induced alterations in hemostasis by different coagulation factor concentrates: significance of studies in vitro with circulating human blood PLoS One 8 2013 e78696
7. A.C. Martin, I. Gouin-Thibault, V. Siguret, A. Mordohay, C.M. Samama, and P. Gaussem Multimodal assessment of non-specific hemostatic agents for apixaban reversal J Thromb Haemost 2015 10.1111/jth.12830
8. G. Agnelli, H.R. Buller, A. Cohen, M. Curto, A.S. Gallus, and M. Johnson Oral apixaban for the treatment of acute venous thromboembolism N Engl J Med 369 2013 799 808
9. S.J. Connolly, J. Eikelboom, C. Joyner, H.C. Diener, R. Hart, and S. Golitsyn Apixaban in patients with atrial fibrillation N Engl J Med 364 2011 806 817
10. I. Gouin-Thibault, C. Flaujac, X. Delavenne, S. Quenet, M.H. Horellou, and S. Laporte Assessment of apixaban plasma levels by laboratory tests: suitability of three anti-Xa assays. A multicentre French GEHT study Thromb Haemost 111 2014 240 248
11. J. Douxfils, C. Chatelain, B. Chatelain, J.M. Dogné, and F. Mullier Impact of apixaban on routine and specific coagulation assays: a practical laboratory guide Thromb Haemost 110 2013 283 294
12. A. Hillarp, K.M. Gustafsson, L. Faxälv, K. Strandberg, F. Baghaei, and I. Fagerberg Blixter Effects of the oral, direct factor Xa inhibitor apixaban on routine coagulation assays and anti-FXa assays J Thromb Haemost 12 2014 [1545-53.5851]
13. H.C. Hemker, P. Giesen, R. Al Dieri, V. Regnault, E. de Smedt, and R. Wagenvoord Calibrated automated thrombin generation measurement in clotting plasma Pathophysiol Haemost Thromb 33 2003 4 15
14. V. Chantarangkul, M. Clerici, C. Bressi, P.L. Giesen, and A. Tripodi Thrombin generation assessed as endogenous thrombin potential in patients with hyper- or hypo-coagulability Haematologica 88 2003 547 554
15. C. Frost, S. Nepal, J. Wang, A. Schuster, W. Byon, and R.A. Boyd Safety, pharmacokinetics and pharmacodynamics of multiple oral doses of apixaban, a factor Xa inhibitor, in healthy subjects Br J Clin Pharmacol 76 2013 776 786
16. M. Ninivaggi, Y. Dargaud, R. van Oerle, B. de Laat, H.C. Hemker, and T. Lindhout Thrombin generation assay using factor IXa as a trigger to quantify accurately factor VIII levels in haemophilia A J Thromb Haemost 9 2011 1549 1555
17. M.M. Samama, J.L. Martinoli, L. LeFlem, C. Guinet, G. Plu-Bureau, and F. Depasse Assessment of laboratory assays to measure rivaroxaban-an oral, direct factor Xa inhibitor Thromb Haemost 103 2010 815 825
18. A. Tripodi, V. Chantarangkul, C. Guinet, and M.M. Samama The International Normalized Ratio calibrated for rivaroxaban has the potential to normalize prothrombin time results for rivaroxaban-treated patients: results of an in vitro study J Thromb Haemost 9 2011 226 228
19. R. Luddington, and T. Baglin Clinical measurement of thrombin generation by calibrated automated thrombography requires contact factor inhibition J Thromb Haemost 2 2004 1954 1959
20. H.M. Spronk, A.W. Dielis, M. Panova-Noeva, R. van Oerle, J.W. Govers-Riemslag, and K. Hamulyák Monitoring thrombin generation: is addition of corn trypsin inhibitor needed? Thromb Haemost 101 2009 1156 1162
21. A. Tripodi, V. Chantarangkul, and E. Santagostino Failure of corn trypsin inhibitor to affect the thrombin generation assay in plasma from severe haemophiliacs: comment J Thromb Haemost 13 2015 163 164
22. A. Tripodi, V. Chantarangkul, M.E. Mancuso, L. Lemma, M. Clerici, and E. Santagostino Comparison of thrombin generation for paired-platelet-rich plasma collected with and without corn trypsin inhibitor from hemophiliacs treated with factor-VIII inhibitor bypassing agents J Thromb Haemost 10 2012 716 719